+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Polymerase Chain Reaction Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026

  • ID: 4851952
  • Report
  • Region: Global
  • 190 pages
  • Transparency Market Research
1 of 2

Polymerase Chain Reaction (PCR) Market - Overview

This comprehensive report analyzes the global PCR market for the period between 2018 and 2026. An in-depth and unbiased market assessment has been made, which offers readers an in-depth and accurate analysis. Market projections have been offered in terms of value (US$ Mn). Stakeholders of this report include companies and intermediaries engaged in research & development of diagnostic reagents, instruments, and consumables; PCR service providers, research and development laboratories, clinical diagnostic laboratories, and academic and research institutes involved in the clinical diagnosis and research activities related to PCR technology.

The global PCR market has been studied for the forecast period from 2018 to 2026. For research, 2017 has been considered as the base year and 2016 as the historical year. The global PCR market report comprises an elaborate executive summary that provides overall information about various segments of the market. The report provides a detailed competitive landscape, by major players operating in this market along with their shares (value %) of the global PCR market for 2017. The report also provides detail company profiles of emerging market players operating in the global PCR market.

The market overview section comprises impact factors such as key market dynamics including drivers, restraints, and opportunities, affecting the global PCR market. These factors are likely to aid stakeholders establish a strong foothold in the global PCR market. Furthermore, the market overview section comprises key industry events, product portfolio overview of leading players and market attractiveness analysis in the global PCR market. The market attractiveness analysis provides a graphical view comparing the expansion and market dynamics in various segments and countries to identify the most attractive market.

Scope

The global PCR market has been segmented based product and end-user. In terms of product, the global PCR market has been segmented into instruments, reagents, and consumables. The instruments segment has been further sub-segmented into standard PCR, RT PCR, and digital PCR. In terms of end-user, the global PCR market has been categorized into pharmaceutical and biotechnology industries, clinical diagnostics labs and hospitals, academic and research organizations, and others.

In terms of geography, the global PCR market has been segmented into North America, Europe, Asia Pacific, and Rest of the World. Moreover, quantitative analysis for major countries comprising the U.S., Canada, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Australia & New Zealand, has also been provided in the report. A detailed qualitative analysis of factors responsible for driving and restraining the PCR market in various regions has been provided in this section.

The report provides a detailed outline/blueprint of the PCR market globally that is expected to assist new companies establish their presence and market players in expanding their share in the market. The report concludes with the company profile section, which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies, and recent developments for market players.

Competitive landscape

Major players operating in the global PCR market include Bio-Rad Laboratories, Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc. Becton, Dickinson and Company, Abbott, Siemens Healthcare GmbH (Siemens AG), bioMérieux SA, Danaher Corporation, and Agilent Technologies.

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global PCR Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Trends
4.4. Global PCR Market Analysis and Forecast, 2016-2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis

5. Market Outlook
5.1. Product Portfolio Analysis, by Key Players
5.2. Distributor Analysis, by Key Players
5.3. End-user Expectations from PCR Reagents & Instruments Manufacturers
5.4. Market Value Share Analysis (%): by PCR Technology
5.5 Clinical Diagnostic PCR Value Share (%) by Type of Diseases/Disorder

6. Global PCR Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2016-2026
6.3.1. Instruments
6.3.1.1. Standard PCR Systems
6.3.1.2. RT PCR Systems
6.3.1.3. Digital PCR Systems
6.3.2. Reagents
6.3.3. Consumables
6.4. Market Attractiveness, by Product

7. Global PCR Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2016-2026
7.3.1. Pharmaceutical and Biotechnology Industries
7.3.2. Clinical Diagnostics Labs and Hospitals
7.3.3. Academic and Research Organizations
7.3.4. Others
7.4. Market Attractiveness, by End-user

8. Global PCR Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Rest of the World
8.3. Market Attractiveness, by Country/Region

9. North America PCR Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2016-2026
9.2.1. Instruments
9.2.1.1. Standard PCR Systems
9.2.1.2. RT PCR Systems
9.2.1.3. Digital PCR Systems
9.2.2. Reagents
9.2.3. Consumables
9.3. Market Value Forecast, by End-user, 2016-2026
9.3.1. Pharmaceutical and Biotechnology Industries
9.3.2. Clinical Diagnostics Labs and Hospitals
9.3.3. Academic and Research Organizations
9.3.4. Others
9.4. Market Value Forecast, by Country, 2016-2026
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country

10. Europe PCR Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2016-2026
10.2.1. Instruments
10.2.1.1. Standard PCR Systems
10.2.1.2. RT PCR Systems
10.2.1.3. Digital PCR Systems
10.2.2. Reagents
10.2.3. Consumables
10.3. Market Value Forecast, by End-user, 2016-2026
10.3.1. Pharmaceutical and Biotechnology Industries
10.3.2. Clinical Diagnostics Labs and Hospitals
10.3.3. Academic and Research Organizations
10.3.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2016-2026
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region

11. Asia Pacific PCR Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2016-2026
11.2.1. Instruments
11.2.1.1. Standard PCR Systems
11.2.1.2. RT PCR Systems
11.2.1.3. Digital PCR Systems
11.2.2. Reagents
11.2.3. Consumables
11.3. Market Value Forecast, by End-user, 2016-2026
11.3.1. Pharmaceutical and Biotechnology Industries
11.3.2. Clinical Diagnostics Labs and Hospitals
11.3.3. Academic and Research Organizations
11.3.4. Others
11.4. Market Value Forecast, by Country/Sub-region, 2016-2026
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. by Product
11.5.2. by End-user
11.5.3. by Country/Sub-region

12. Rest of the World PCR Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2016-2026
12.2.1. Instruments
12.2.1.1. Standard PCR Systems
12.2.1.2. RT PCR Systems
12.2.1.3. Digital PCR Systems
12.2.2. Reagents
12.2.3. Consumables
12.3. Market Value Forecast, by End-user, 2016-2026
12.3.1. Pharmaceutical and Biotechnology Industries
12.3.2. Clinical Diagnostics Labs and Hospitals
12.3.3. Academic and Research Organizations
12.3.4. Others
12.4. Market Attractiveness Analysis
12.4.1. by Product
12.4.2. by End-user

13. Competition Landscape
13.1. Market Player - Competition Matrix Competition Matrix (by Tier and Size of Companies)
13.2. Market Share Analysis by Company (2017)
13.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
13.3.1. Bio-Rad Laboratories, Inc.
13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.1.2. Product Portfolio
13.3.1.3. SWOT Analysis
13.3.1.4. Financial Overview
13.3.1.5. Strategic Overview
13.3.2. Qiagen N.V.
13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2.2. Product Portfolio
13.3.2.3. SWOT Analysis
13.3.2.4. Financial Overview
13.3.2.5. Strategic Overview
13.3.3. F. Hoffmann-La Roche AG
13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.3.2. Product Portfolio
13.3.3.3. SWOT Analysis
13.3.3.4. Financial Overview
13.3.3.5. Strategic Overview
13.3.4. Thermo Fisher Scientific, Inc.
13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.4.2. Product Portfolio
13.3.4.3. SWOT Analysis
13.3.4.4. Financial Overview
13.3.4.5. Strategic Overview
13.3.5. Becton, Dickinson and Company
13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.5.2. Product Portfolio
13.3.5.3. SWOT Analysis
13.3.5.4. Financial Overview
13.3.5.5. Strategic Overview
13.3.6. Abbott
13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.6.2. Product Portfolio
13.3.6.3. SWOT Analysis
13.3.6.4. Financial Overview
13.3.6.5. Strategic Overview
13.3.7. Siemens Healthcare GmbH (Siemens AG)
13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.7.2. Product Portfolio
13.3.7.3. SWOT Analysis
13.3.7.4. Financial Overview
13.3.7.5. Strategic Overview
13.3.8. BioMérieux SA
13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.8.2. Product Portfolio
13.3.8.3. SWOT Analysis
13.3.8.4. Financial Overview
13.3.8.5. Strategic Overview
13.3.9. Danaher Corporation
13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.9.2. Product Portfolio
13.3.9.3. SWOT Analysis
13.3.9.4. Financial Overview
13.3.9.5. Strategic Overview
13.3.10. Agilent Technologies
13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.10.2. Product Portfolio
13.3.10.3. SWOT Analysis
13.3.10.4. Financial Overview
13.3.10.5. Strategic Overview
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll